Pills masthead

Fundamentals

Select the financial statements you wish to view below.  The reports below may be viewed on either an annual or quarterly basis.

NYSELCI
All numbers in thousands USD
Period Ending
Jun 30, 2022
Jun 30, 2021
Jun 30, 2020
Jun 30, 2019
Total Revenue
340,579
478,778
545,744
655,407
Cost of Revenue
307,413
403,185
380,524
411,797
Gross Profit
33,166
75,593
165,220
243,610
Operating Expenses
Research Development
22,362
24,173
29,978
38,807
Selling General and Administrative
81,023
68,078
79,467
87,648
Non Recurring
--
--
--
--
Others
0
0
0
0
Total Operating Expenses
103,385
92,251
109,445
126,455
Operating Income or Loss
(70,219)
(16,658)
55,775
117,155
Income from Continuing Operations
Total Other Income/Expenses Net
(105,726)
(232,362)
(37,558)
(378,776)
Earnings Before Interest And Taxes
(175,945)
(249,020)
18,217
(261,621)
Interest Expense
57,979
53,830
66,845
84,624
Income Before Tax
(233,924)
(302,850)
(48,628)
(346,245)
Income Tax Expense
(2,304)
60,625
(15,262)
(74,138)
Minority Interest
--
--
--
--
Net Income From Continuing Ops
(231,620)
(363,475)
(33,366)
(272,107)
Non-recurring Events
Discontinued Operations
--
--
--
--
Extraordinary Items
--
--
--
--
Effect Of Accounting Changes
--
--
--
--
Other Items
0
0
0
0
Net Income
(231,620)
(363,475)
(33,366)
(272,107)
Preferred Stock And Other Adjustments
--
--
--
--
Net Income Applicable To Common Shares
(231,620)
(363,475)
(33,366)
(272,107)